Skip to main content
NCBI home page
Environmental Health Perspectives logoLink to Environmental Health Perspectives
. 1978 Oct;26:135–141. doi: 10.1289/ehp.7826135

Central neurotransmitter function and its behavioral correlates in man.

I Hanin
PMCID: PMC1637265  PMID: 31279

Abstract

The past decade has witnessed a tremendous increase in knowledge towards understanding the function of various brain neurotransmitter substances in behavior. Experimental observations in animals, utilizing specific pharmacological agents, have enabled the development of certain hypotheses regarding neurochemical substrates of behavior. These have led to cautious applications of complementary studies in humans. As a result, several neurotransmitter-related hypotheses have been developed for the explanation of normal behaviour, as well as of various abnormal behavior states in psychiatry and neurology. These hypotheses are currently undergoing extensive investigation. Highlights of the above sequence of events are presented, in order to provide as general, yet extensive, an overview of the subject as possible. Examples are provided from both basic laboratory investigations and from clinical findings. Principles of brain neurotransmitter function and interactions are reviewed. Various neurotransmitter-related hypothese of psychiatric and neurologic interest are introduced. Finally, the role that toxicants may have on behavior via alteration of brain neurotransmitter function is discussed, using the lead intoxicated animals as an illustrative example.

Full text

PDF
135

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Axelrod J. Neurotransmitters. Sci Am. 1974 Jun;230(6):59–71. [PubMed] [Google Scholar]
  2. Bloom F. E., Costa E., Salmoiraghi G. C. Anesthesia and the responsiveness of individual neurons of the caudate nucleus of the cat to acetylcholine, norepinephrine and dopamine administered by microelectrophoresis. J Pharmacol Exp Ther. 1965 Nov;150(2):244–252. [PubMed] [Google Scholar]
  3. Bunney W. E., Jr, Davis J. M. Norepinephrine in depressive reactions. A review. Arch Gen Psychiatry. 1965 Dec;13(6):483–494. doi: 10.1001/archpsyc.1965.01730060001001. [DOI] [PubMed] [Google Scholar]
  4. Campbell L. B., Jenden D. J. Gas chromatographic evaluation of the influence of oxotremorine upon the regional distribution of acetylcholine in rat brain. J Neurochem. 1970 Dec;17(12):1697–1699. doi: 10.1111/j.1471-4159.1970.tb11396.x. [DOI] [PubMed] [Google Scholar]
  5. Carlsson A., Corrodi H., Fuxe K., Hökfelt T. Effect of antidepressant drugs on the depletion of intraneuronal brain 5-hydroxytryptamine stores caused by 4-methyl-alpha-ethyl-meta-tyramine. Eur J Pharmacol. 1969 Mar;5(4):357–366. doi: 10.1016/0014-2999(69)90113-7. [DOI] [PubMed] [Google Scholar]
  6. Carlsson A., Corrodi H., Fuxe K., Hökfelt T. Effects of some antidepressant drugs on the depletion of intraneuronal brain catecholamine stores caused by 4,alpha-dimethyl-meta-tyramine. Eur J Pharmacol. 1969 Mar;5(4):367–373. doi: 10.1016/0014-2999(69)90114-9. [DOI] [PubMed] [Google Scholar]
  7. Carlsson A., Fuxe K., Hamberger B., Lindqvist M. Biochemical and histochemical studies on the effects of imipramine-like drugs and (+)-amphetamine on central and peripheral catecholamine neurons. Acta Physiol Scand. 1966 Jul-Aug;67(3):481–497. doi: 10.1111/j.1748-1716.1966.tb03334.x. [DOI] [PubMed] [Google Scholar]
  8. Chang L. W. Neurotoxic effects of mercury--a review. Environ Res. 1977 Dec;14(3):329–373. doi: 10.1016/0013-9351(77)90044-5. [DOI] [PubMed] [Google Scholar]
  9. Colasanti B. K., Craig C. R. Brain concentrations and synthesis rates of biogenic amines during chronic cobalt experimental epilepsy in the rat. Neuropharmacology. 1973 Mar;12(3):221–231. doi: 10.1016/0028-3908(73)90106-8. [DOI] [PubMed] [Google Scholar]
  10. Connor J. D. Caudate nucleus neurones: correlation of the effects of substantia nigra stimulaton with iontophoretic dopamine. J Physiol. 1970 Jul;208(3):691–703. doi: 10.1113/jphysiol.1970.sp009143. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. DENGLER H. J., SPIEGEL H. E., TITUS E. O. Effects of drugs on uptake of isotopic norepinephrine by cat tissues. Nature. 1961 Aug 19;191:816–817. doi: 10.1038/191816a0. [DOI] [PubMed] [Google Scholar]
  12. Davis K. L., Hollister L. E., Berger P. A., Barchas J. D. Cholinergic imbalance hypotheses of psychoses and movement disorders: strategies for evaluation. Psychopharmacol Commun. 1975;1(5):533–543. [PubMed] [Google Scholar]
  13. Dekirmenjian H., Maas J. 3-Methoxy-4-hydroxyphenethylene glycol in plasma. Clin Chim Acta. 1974 Apr;52(2):203–210. doi: 10.1016/0009-8981(74)90211-3. [DOI] [PubMed] [Google Scholar]
  14. Koe B. K. Molecular geometry of inhibitors of the uptake of catecholamines and serotonin in synaptosomal preparations of rat brain. J Pharmacol Exp Ther. 1976 Dec;199(3):649–661. [PubMed] [Google Scholar]
  15. Maas J. W. Biogenic amines and depression. Biochemical and pharmacological separation of two types of depression. Arch Gen Psychiatry. 1975 Nov;32(11):1357–1361. doi: 10.1001/archpsyc.1975.01760290025002. [DOI] [PubMed] [Google Scholar]
  16. McLennan H., York D. H. The action of dopamine on neurones of the caudate nucleus. J Physiol. 1967 Apr;189(3):393–402. doi: 10.1113/jphysiol.1967.sp008175. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Neff N. H., Barrett R. E., Costa E. Selective depletion of caudate nucleus dopamine and serotonin during chronic manganese dioxide administration to squirrel monkeys. Experientia. 1969 Nov 15;25(11):1140–1141. doi: 10.1007/BF01900234. [DOI] [PubMed] [Google Scholar]
  18. Ross S. B., Renyl A. L. Accumulation of tritiated 5-hydroxytryptamine in brain slices. Life Sci. 1967 Jul 1;6(13):1407–1415. doi: 10.1016/0024-3205(67)90188-9. [DOI] [PubMed] [Google Scholar]
  19. SHORE P. A. Release of serotonin and catecholamines by drugs. Pharmacol Rev. 1962 Dec;14:531–550. [PubMed] [Google Scholar]
  20. STEIN L. SELF-STIMULATION OF THE BRAIN AND THE CENTRAL STIMULANT ACTION OF AMPHETAMINE. Fed Proc. 1964 Jul-Aug;23:836–850. [PubMed] [Google Scholar]
  21. Schildkraut J. J. The catecholamine hypothesis of affective disorders: a review of supporting evidence. Am J Psychiatry. 1965 Nov;122(5):509–522. doi: 10.1176/ajp.122.5.509. [DOI] [PubMed] [Google Scholar]
  22. Snyder S. H. The dopamine hypothesis of schizophrenia: focus on the dopamine receptor. Am J Psychiatry. 1976 Feb;133(2):197–202. doi: 10.1176/ajp.133.2.197. [DOI] [PubMed] [Google Scholar]
  23. Ungerstedt U. Stereotaxic mapping of the monoamine pathways in the rat brain. Acta Physiol Scand Suppl. 1971;367:1–48. doi: 10.1111/j.1365-201x.1971.tb10998.x. [DOI] [PubMed] [Google Scholar]
  24. Weiss B. The behavioral toxicology of metals. Fed Proc. 1978 Jan;37(1):22–27. [PubMed] [Google Scholar]

Articles from Environmental Health Perspectives are provided here courtesy of National Institute of Environmental Health Sciences

RESOURCES